BRAMPTON, ON, Nov. 13,
2024 /CNW/ - Loblaw Companies Limited (TSX: L)
("Loblaw" or the "Company") announced today its unaudited financial
results for the third quarter ended October
5, 2024(1).
Loblaw delivered another quarter of consistent operational and
financial performance as it continued to provide value to Canadians
across its retail network, while maintaining its focus on retail
excellence. The reversal of a charge related to a previous
President's Choice Bank ("PC Bank") commodity tax matter positively
impacted net earnings by $125
million. Drug Retail sales growth outperformed Food Retail
in the quarter. Drug front store sales reflected continued strength
in the beauty category but were pressured by the Company's exit
from certain low margin electronics categories and lower customer
spend on convenience items. Pharmacy and healthcare services
revenue increased due to ongoing strength in acute and chronic
prescriptions. Food Retail stores attracted increased customer
visits in the quarter, despite Thanksgiving holiday sales shifting
into the fourth quarter this year. Food sales growth reflected the
ongoing strength of the Company's Maxi and NoFrills hard
discount stores, and its growing selection of multicultural foods
across its banners, anchored by strong performance in the T&T
banner. In the quarter, the Company continued to invest in its
network of stores, including opening 25 new hard discount stores
and piloting two new ultra-discount no name® stores.
"Increased customer traffic to our stores this quarter
demonstrates that we are delivering the value, quality and service
our customers count on," said Per
Bank, President and Chief Executive Officer, Loblaw
Companies Limited. "Our relentless focus on retail excellence
allows us to provide great value to Canadians and invest to deliver
future growth, while delivering strong financial results."
2024 THIRD QUARTER HIGHLIGHTS
- Revenue was $18,538 million, an
increase of $273 million, or
1.5%.
- Retail segment sales were $18,259
million, an increase of $277
million, or 1.5%.
-
- Food Retail (Loblaw) same-stores sales increased by 0.5%,
compared to 4.5% last year. Food retail same-store sales growth was
approximately 1.3% after excluding the unfavourable impact of the
timing of Thanksgiving.
- Drug Retail (Shoppers Drug Mart) same-store sales increased by
2.9%, compared to 4.6% last year, with pharmacy and healthcare
services same-store sales growth of 6.3%, partially offset by a
decline in front store same-store sales of 0.5%. The timing of
Thanksgiving had a nominal impact on same-store sales growth for
Drug retail in the third quarter of 2024.
- E-commerce sales increased by 18.5%.
- Operating income was $1,321
million, an increase of $256
million, or 24.0%.
- Adjusted EBITDA(2) was $2,069
million, an increase of $143
million, or 7.4%.
- Retail segment gross profit percentage(2) was 30.9%,
an increase of 30 basis points, primarily driven by improvements in
shrink.
- Net earnings available to common shareholders of the Company
were $777 million, an increase of
$156 million or 25.1%.
- Diluted net earnings per common share were $2.53, an increase of $0.58, or 29.7%. The increase included the
recovery of $165 million
($125 million, net of income taxes)
related to a PC Bank commodity tax matter.
- Adjusted net earnings available to common shareholders of the
Company(2) were $767
million, an increase of $48
million, or 6.7%.
- Adjusted diluted net earnings per common share(2)
were $2.50, an increase of
$0.24 or 10.6%.
- Net capital investments were $429
million, which reflects gross capital investments of
$690 million, net of proceeds from
property disposals of $261
million.
- Repurchased for cancellation 2.65 million common shares at a
cost of $450 million. Free cash
flow(2) from the Retail segment was $562 million.
See "News Release
Endnotes" at the end of this News Release.
|
CONSOLIDATED AND SEGMENT RESULTS OF OPERATIONS
The following table provides key performance metrics for the
Company by segment.
|
|
|
|
2024
(16 weeks)
|
|
|
|
2023
(16 weeks)
|
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
Retail
|
Financial
Services
|
|
Elimi-
nations
|
|
Total
|
|
|
|
Retail
|
Financial
Services
|
|
Elimi-
nations
|
|
|
Total
|
(millions of Canadian
dollars except where otherwise indicated)
|
|
|
Revenue
|
|
|
$
|
18,259
|
$
382
|
$
|
(103)
|
$
|
18,538
|
|
|
$
|
17,982
|
$
379
|
$
|
(96)
|
|
$
|
18,265
|
Gross
profit(2)
|
|
|
$
|
5,642
|
$
334
|
$
|
(103)
|
$
|
5,873
|
|
|
$
|
5,502
|
$
325
|
$
|
(96)
|
|
$
|
5,731
|
Gross profit
%(2)
|
|
|
|
30.9 %
|
N/A
|
|
— %
|
|
31.7 %
|
|
|
|
30.6 %
|
N/A
|
|
— %
|
|
|
31.4 %
|
Operating
income
|
|
|
$
|
1,091
|
$
230
|
$
|
—
|
$
|
1,321
|
|
|
$
|
1,006
|
$ 59
|
$
|
—
|
|
$
|
1,065
|
Adjusted operating
income(2)
|
|
|
|
1,246
|
75
|
|
—
|
|
1,321
|
|
|
|
1,141
|
59
|
|
—
|
|
|
1,200
|
Adjusted
EBITDA(2)
|
|
|
$
|
1,982
|
$ 87
|
$
|
—
|
$
|
2,069
|
|
|
$
|
1,852
|
$ 74
|
$
|
—
|
|
$
|
1,926
|
Adjusted EBITDA
margin(2)
|
|
|
|
10.9 %
|
N/A
|
|
— %
|
|
11.2 %
|
|
|
|
10.3 %
|
N/A
|
|
— %
|
|
|
10.5 %
|
Net interest expense
and other financing charges
|
|
|
$
|
209
|
$ 29
|
$
|
—
|
$
|
238
|
|
|
$
|
197
|
$ 37
|
$
|
—
|
|
$
|
234
|
Adjusted net interest
expense and other financing charges(2)
|
|
|
|
209
|
39
|
|
—
|
|
248
|
|
|
|
197
|
37
|
|
—
|
|
|
234
|
Earnings before
income taxes
|
|
|
$
|
882
|
$
201
|
$
|
—
|
$
|
1,083
|
|
|
$
|
809
|
$ 22
|
$
|
—
|
|
$
|
831
|
Income taxes
|
|
|
|
|
|
|
|
$
|
263
|
|
|
|
|
|
|
|
|
$
|
182
|
Adjusted income
taxes(2)
|
|
|
|
|
|
|
|
|
263
|
|
|
|
|
|
|
|
|
|
219
|
Net earnings
attributable to non-controlling interests
|
|
|
|
|
|
|
|
$
|
40
|
|
|
|
|
|
|
|
|
$
|
25
|
Prescribed dividends on
preferred shares in share capital
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
3
|
Net earnings
available to common shareholders of the Company
|
|
|
|
|
|
|
|
$
|
777
|
|
|
|
|
|
|
|
|
$
|
621
|
Adjusted net earnings
available to common shareholders of the
Company(2)
|
|
|
|
|
|
|
|
|
767
|
|
|
|
|
|
|
|
|
|
719
|
Diluted net earnings
per common share ($)
|
|
|
|
|
|
|
|
$
|
2.53
|
|
|
|
|
|
|
|
|
$
|
1.95
|
Adjusted diluted net
earnings per common share(2) ($)
|
|
|
|
|
|
|
|
$
|
2.50
|
|
|
|
|
|
|
|
|
$
|
2.26
|
Diluted weighted
average common shares outstanding (in millions)
|
|
|
|
|
|
|
|
|
306.9
|
|
|
|
|
|
|
|
|
|
318.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table provides a breakdown of the Company's total
and same-store sales for the Retail segment.
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
2024
(16
weeks)
|
|
|
2023
(16 weeks)
|
(millions of Canadian
dollars except where otherwise indicated)
|
|
|
|
|
|
|
|
Sales
|
Same-store
sales
|
|
|
Sales
|
Same-store
sales
|
Food retail
|
|
|
$
12,966
|
0.5 %
|
|
|
$ 12,843
|
4.5 %
|
Drug retail
|
|
|
5,293
|
2.9 %
|
|
|
5,139
|
4.6 %
|
Pharmacy and
healthcare services
|
|
|
2,783
|
6.3 %
|
|
|
2,635
|
7.4 %
|
Front store
|
|
|
2,510
|
(0.5) %
|
|
|
2,504
|
1.8 %
|
|
|
|
|
|
|
|
|
|
RETAIL SEGMENT
- Retail segment sales in the third quarter of 2024 were
$18,259 million, an increase of
$277 million, or 1.5%.
-
- Food Retail (Loblaw) sales were $12,966
million and same-store sales grew by 0.5% (2023 – 4.5%).
Food retail same-store sales growth was approximately 1.3% after
excluding the unfavourable impact of the timing of
Thanksgiving.
-
-
- The Consumer Price Index as measured by The Consumer Price
Index for Food Purchased From Stores was 2.3% (2023 – 7.1%) which
was lower than the Company's internal food inflation; and
- Food Retail traffic increased and basket size decreased.
-
- Drug Retail (Shoppers Drug Mart) sales were $5,293 million, and same-store sales grew by 2.9%
(2023 – 4.6%), with pharmacy and healthcare services same-store
sales growth of 6.3% (2023 – 7.4%), partially offset by a decline
in front store same-store sales of 0.5% (2023 – growth of 1.8%).
The timing of Thanksgiving had a nominal impact on same-store sales
growth for Drug retail in the third quarter of 2024.
-
-
- On a same-store basis, the number of prescriptions increased by
2.3% (2023 – 0.9%) and the average prescription value increased by
3.5% (2023 – 5.1%).
- The decline in front store same-store sales was primarily
driven by lower sales of food and household items and the decision
to exit certain low margin electronics categories, partially offset
by the continued strength in beauty products.
- Operating income in the third quarter of 2024 was $1,091 million, an increase of $85 million, or 8.4%.
- Gross profit(2) in the third quarter of 2024 was
$5,642 million, an increase of
$140 million, or 2.5%. The gross
profit percentage(2) of 30.9% increased by 30 basis
points, primarily driven by improvements in shrink.
- Adjusted EBITDA(2) in the third quarter of 2024 was
$1,982 million, an increase of
$130 million, or 7.0%. The increase
was driven by an increase in gross profit(2), partially
offset by an increase in selling, general and administrative
expenses ("SG&A"). SG&A as a percentage of sales was 20.0%,
a favourable decrease of 30 basis points, primarily due to the
year-over-year impact of certain real estate activities and
operating leverage, partially offset by incremental costs related
to opening new stores.
- Depreciation and amortization in the third quarter of 2024 was
$891 million, an increase of
$26 million or 3.0%, primarily driven
by an increase in depreciation of information technology ("IT")
assets and leased assets, and an increase in depreciation of fixed
assets related to conversions of retail locations. Included in
depreciation and amortization was the amortization of intangible
assets related to the acquisitions of Shoppers Drug Mart
Corporation ("Shoppers Drug Mart") and Lifemark Health Group
("Lifemark") of $155 million (2023 –
$154 million).
FINANCIAL SERVICES SEGMENT
- Revenue in the third quarter of 2024 was $382 million, an increase of $3 million or 0.8%. The increase was primarily
driven by higher interchange and credit card fee income, partially
offset by lower sales attributable to The Mobile Shop™.
- Earnings before income taxes in the third quarter of 2024 were
$201 million, an increase of
$179 million. The increase was mainly
driven by a recovery of $165 million
related to a commodity tax matter, including $10 million of interest income, lower customer
acquisition expenses and operating costs, including the ongoing
benefits associated with the renewal of a long-term agreement with
Mastercard, and higher revenue as described above. This increase
was partially offset by higher contractual charge-offs and higher
loyalty program costs.
- In July 2022, the Tax Court of
Canada ("Tax Court") released a
decision relating to PC Bank, a subsidiary of the Company. The Tax
Court ruled that PC Bank is not entitled to claim notional input
tax credits for certain payments it made to Loblaws Inc. in respect
of redemptions of loyalty points. PC Bank subsequently filed a
Notice of Appeal with the Federal Court of Appeal ("FCA") and in
March 2024, the matter was heard by
the FCA. In August 2024, the FCA
released its decision and reversed the decision of the Tax Court.
As a result, PC Bank reversed charges of $155 million, including $111 million initially recorded in the second
quarter of 2022. In addition, $10
million was recorded related to interest income on cash tax
refunds.
OUTLOOK(3)
Loblaw will continue to execute on retail excellence while
advancing its growth initiatives with the goal of delivering
consistent operational and financial results in 2024. The Company's
businesses remain well positioned to meet the everyday needs of
Canadians.
For the full-year 2024, the Company continues to expect:
- its Retail business to grow earnings faster than sales;
and
- to return capital to shareholders by allocating a significant
portion of free cash flow to share repurchases.
Based on its year-to-date operating and financial performance
and momentum exiting the third quarter, the Company is slightly
increasing its guidance for full year adjusted net earnings per
common share(2) growth from high single-digits into the
low double-digits.
Additionally, based on the year-to-date investments in its store
network and distribution centres, the Company now expects to invest
a net amount of $1.9 billion in
capital expenditures (previously $1.8
billion), which reflects gross capital investments of
approximately $2.3 billion
(previously $2.2 billion), net of
approximately $400 million of
proceeds from property disposals.
ENVIRONMENTAL, SOCIAL AND GOVERNANCE ("ESG")
In the third quarter of 2024, the Company progressed its ESG
pillars:
- Fighting Climate Change: Loblaw continued to make
progress towards its commitment to have all control brand and
in-store plastic packaging aligned to the Consumer Goods Forum's
Golden Design Rules by 2025 (a set of internationally accepted
rules to improve plastic packaging design and reduce plastic
waste). In the third quarter of 2024, the Company made significant
progress in converting its frozen control brand plastic packaging
to the applicable Golden Design Rules which make them recycle
ready(4).
Loblaw also made a donation in
support of Second Harvest's "Waste Wise" campaign which focuses on
ways Canadians can reduce the amount of food wasted at home.
- Advancing Social Equity: The Company launched its second
Get to Give DaysTM initiative, donating $2 million through proceeds from the sale of
President's Choice products to President's Choice Children's
Charity ("PCCC"). This supported PCCC's mission of feeding 1
million kids annually through its Power Full KidsTM
program in schools across Canada
by the end of 2025. To celebrate the Get to Give DaysTM
initiative, colleagues from across the country also came together
to pack more than 473,000 snack bags which were delivered to local
schools.
Beyond support for PCCC, the Company also raised more than
$1 million in local community
donations through its annual Give a Little Help A Lot® campaign to
support important local initiatives such as the Daily Bread Food
Bank and the North York Women's Shelter.
NORMAL COURSE ISSUER BID PROGRAM ("NCIB")
On a year-to-date basis, the Company repurchased
9.0 million common shares for cancellation at a cost of
$1,402 million.
From time to time, the Company participates in an automatic
share purchase plan ("ASPP") with a broker in order to facilitate
the repurchase of the Company's common shares under its NCIB.
During the effective period of the ASPP, the Company's broker may
purchase common shares at times when the Company would not be
active in the market.
FORWARD-LOOKING STATEMENTS
This News Release contains forward-looking statements about the
Company's objectives, plans, goals, aspirations, strategies,
financial condition, results of operations, cash flows,
performance, prospects, opportunities and legal and regulatory
matters. Specific forward-looking statements in this News Release
include, but are not limited to, statements with respect to the
Company's anticipated future results, events and plans, strategic
initiatives and restructuring, regulatory changes including further
healthcare reform, future liquidity, planned capital investments,
and the status and impact of IT systems implementations. These
specific forward-looking statements are contained throughout this
News Release including, without limitation, in the "Consolidated
and Segment Results of Operations" and "Outlook" section of this
News Release. Forward-looking statements are typically identified
by words such as "expect", "anticipate", "believe", "foresee",
"could", "estimate", "goal", "intend", "plan", "seek", "strive",
"will", "may", "should" and similar expressions, as they relate to
the Company and its management.
Forward-looking statements reflect the Company's estimates,
beliefs and assumptions, which are based on management's perception
of historical trends, current conditions and expected future
developments, as well as other factors it believes are appropriate
in the circumstances. The Company's estimates, beliefs and
assumptions are inherently subject to significant business,
economic, competitive and other uncertainties and contingencies
regarding future events and, as such, are subject to change. The
Company can give no assurance that such estimates, beliefs and
assumptions will prove to be correct.
Numerous risks and uncertainties could cause the Company's
actual results to differ materially from those expressed, implied
or projected in the forward-looking statements, including those
described in the Company's Management Discussion & Analysis
("MD&A") in the 2023 Annual Report and Section 4 "Risks" of the
Company's 2023 Annual Information Form ("AIF") for the year ended
December 30, 2023.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect the Company's
expectations only as of the date of this News Release. Except as
required by law, the Company does not undertake to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise.
DECLARATION OF DIVIDENDS
Subsequent to the end of the third quarter of 2024, the Board of
Directors declared a quarterly dividend on Common Shares and
Second Preferred Shares, Series B.
Common
Shares
|
$0.513 per common
share, payable on December 30, 2024 to shareholders of
record on December 15, 2024.
|
|
|
Second Preferred
Shares,
Series B
|
$0.33125 per share,
payable on December 31, 2024 to shareholders of record on
December 15, 2024.
|
EXCERPT OF NON-GAAP AND OTHER FINANCIAL MEASURES
The Company uses non-GAAP and other financial measures, as
reconciled and fully described in Appendix 1 "Non-GAAP and Other
Financial Measures" of this News Release.
These measures do not have a standardized meaning prescribed by
International Financial Reporting Standards as issued by the
International Accounting Standards Board ("IFRS Accounting
Standards" or "GAAP"), and therefore they may not be comparable to
similarly titled measures presented by other publicly traded
companies and should not be construed as an alternative to other
financial measures determined in accordance with GAAP.
The following table provides a summary of the differences
between the Company's consolidated GAAP and Non-GAAP and other
financial measures, which are reconciled and fully described in
Appendix 1.
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
2024
|
|
|
2023
|
(millions of Canadian
dollars except where otherwise indicated)
|
|
|
|
(16
weeks)
|
|
|
(16 weeks)
|
|
|
|
|
GAAP
|
Adjusting
Items
|
|
Non-
GAAP(2)
|
|
|
GAAP
|
Adjusting
Items
|
|
Non-
GAAP(2)
|
EBITDA
|
|
|
$
|
2,224
|
$
(155)
|
$
|
2,069
|
|
|
$
1,945
|
$ (19)
|
$
|
1,926
|
Operating
income
|
|
|
$
|
1,321
|
$
—
|
$
|
1,321
|
|
|
$
1,065
|
$ 135
|
$
|
1,200
|
Net interest expense
and other financing charges
|
|
|
|
238
|
10
|
|
248
|
|
|
234
|
—
|
|
234
|
Earnings before
income taxes
|
|
|
$
|
1,083
|
$
(10)
|
$
|
1,073
|
|
|
$ 831
|
$ 135
|
$
|
966
|
Deduct the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
taxes
|
|
|
|
263
|
—
|
|
263
|
|
|
182
|
37
|
|
219
|
Non-controlling
interests
|
|
|
|
40
|
—
|
|
40
|
|
|
25
|
—
|
|
25
|
Prescribed dividends
on preferred shares
|
|
|
|
3
|
—
|
|
3
|
|
|
3
|
—
|
|
3
|
Net earnings
available to common shareholders of the Company(i)
|
|
|
$
|
777
|
$
(10)
|
$
|
767
|
|
|
$ 621
|
$ 98
|
$
|
719
|
Diluted net earnings
per common share ($)
|
|
|
$
|
2.53
|
$
(0.03)
|
$
|
2.50
|
|
|
$ 1.95
|
$ 0.31
|
$
|
2.26
|
Diluted weighted
average common shares (millions)
|
|
|
|
306.9
|
—
|
|
306.9
|
|
|
318.4
|
—
|
|
318.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Net earnings available
to common shareholders of the Company are net earnings attributable
to shareholders of the Company net of dividends declared on the
Company's Second Preferred Shares, Series B.
|
The following table provides a summary of the Company's
adjusting items which are reconciled and fully described in
Appendix 1.
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
2024
|
|
|
|
2023
|
(millions of Canadian
dollars)
|
|
|
|
(16
weeks)
|
|
|
|
(16 weeks)
|
Operating
income
|
|
|
$
|
1,321
|
|
|
$
|
1,065
|
Add (deduct) impact of
the following:
|
|
|
|
|
|
|
|
|
Amortization of
intangible assets acquired with Shoppers Drug Mart and
Lifemark
|
|
|
$
|
155
|
|
|
$
|
154
|
Fair value adjustment
on fuel and foreign currency contracts
|
|
|
|
—
|
|
|
|
(6)
|
Gain on sale of
non-operating properties
|
|
|
|
—
|
|
|
|
(13)
|
Recovery related to PC
Bank commodity tax matter
|
|
|
|
(155)
|
|
|
|
—
|
Adjusting
items
|
|
|
$
|
—
|
|
|
$
|
135
|
Adjusted operating
income(2)
|
|
|
$
|
1,321
|
|
|
$
|
1,200
|
Net interest expense
and other financing charges
|
|
|
$
|
238
|
|
|
$
|
234
|
Add: Recovery related
to PC Bank commodity tax matter
|
|
|
|
10
|
|
|
|
—
|
Adjusted net
interest expense and other financing charge(2)
|
|
|
$
|
248
|
|
|
$
|
234
|
Income
taxes
|
|
|
$
|
263
|
|
|
$
|
182
|
Add the impact of the
following:
|
|
|
|
|
|
|
|
|
Tax impact of items
included in adjusted earnings before taxes
|
|
|
$
|
—
|
|
|
$
|
37
|
Adjusting
items
|
|
|
$
|
—
|
|
|
$
|
37
|
Adjusted income
taxes(2)
|
|
|
$
|
263
|
|
|
$
|
219
|
|
|
|
|
|
|
|
|
|
CORPORATE PROFILE
2023 Annual Report and 2024 Third Quarter Report
to Shareholders
The Company's 2023 Annual Report and 2024 Third Quarter Report
to Shareholders are available in the "Investors" section of the
Company's website at loblaw.ca and on sedarplus.ca.
Additional financial information has been filed electronically
with various securities regulators in Canada through SEDAR+ and with the Office of
the Superintendent of Financial Institutions (OSFI) as the primary
regulator for the Company's subsidiary, President's Choice Bank.
The Company holds an analyst call shortly following the release of
its quarterly results. These calls are archived in the "Investors"
section of the Company's website at loblaw.ca.
Conference Call and Webcast
Loblaw Companies Limited will host a conference call as well as
an audio webcast on November 13, 2024
at 10:00 a.m. (ET).
To access via tele-conference, please dial (416) 945-7677 or
(888) 699-1199. The playback will be made available approximately
two hours after the event at (289) 819-1450 or (888) 660-6345,
access code: 36516#. To access via audio webcast, please go to the
"Investor" section of loblaw.ca. Pre-registration will be
available.
Full details about the conference call and webcast are available
on the Loblaw Companies Limited website at loblaw.ca.
News Release
Endnotes
|
|
|
(1)
|
This News Release
contains forward-looking information. See "Forward-Looking
Statements" section of this News Release and the Company's 2024
Third Quarter Report to Shareholders for a discussion of material
factors that could cause actual results to differ materially from
the forecasts and projections herein and of the material factors
and assumptions that were used when making these statements. This
News Release should be read in conjunction with Loblaw Companies
Limited's filings with securities regulators made from time to
time, all of which can be found at sedarplus.ca and at
loblaw.ca.
|
(2)
|
See "Non-GAAP and Other
Financial Measures" section in Appendix 1 of this News Release,
which includes the reconciliation of such non-GAAP and other
financial measures to the most directly comparable GAAP
measures.
|
(3)
|
To be read in
conjunction with the "Forward-Looking Statements" section of this
News Release and the Company's 2024 Third Quarter Report to
Shareholders.
|
(4)
|
Packaging acceptable
for collection in participating municipal programs only.
|
|
APPENDIX 1: NON-GAAP AND OTHER FINANCIAL MEASURES
The Company uses the following non-GAAP and other financial
measures and ratios: Retail segment gross profit; Retail segment
adjusted gross profit; Retail segment adjusted gross profit
percentage; adjusted earnings before income taxes, net interest
expense and other financing charges and depreciation and
amortization ("adjusted EBITDA"); adjusted EBITDA margin; adjusted
operating income; adjusted net interest expense and other
financing charges; adjusted income taxes; adjusted effective tax
rate; adjusted net earnings available to common shareholders;
adjusted diluted net earnings per common share, free cash flow, and
same-store sales. The Company believes these non-GAAP and other
financial measures and ratios provide useful information to both
management and investors in measuring the financial performance and
financial condition of the Company for the reasons outlined
below.
Management uses these and other non-GAAP and other financial
measures to exclude the impact of certain expenses and income that
must be recognized under GAAP when analyzing underlying
consolidated and segment operating performance, as the excluded
items are not necessarily reflective of the Company's underlying
operating performance and make comparisons of underlying financial
performance between periods difficult. The Company adjusts for
these items if it believes doing so would result in a more
effective analysis of underlying operating performance. The
exclusion of certain items does not imply that they are
non-recurring.
These measures do not have a standardized meaning prescribed by
GAAP and therefore they may not be comparable to similarly titled
measures presented by other publicly traded companies and should
not be construed as an alternative to other financial measures
determined in accordance with GAAP.
Retail Segment Gross Profit, Retail Segment Adjusted Gross
Profit and Retail Segment Adjusted Gross Profit
Percentage The following tables reconcile adjusted gross
profit by segment to gross profit by segment, which is reconciled
to revenue and cost of sales measures as reported in the
consolidated statements of earnings for the periods ended as
indicated. The Company believes that Retail segment gross profit
and Retail segment adjusted gross profit are useful in assessing
the Retail segment's underlying operating performance and in making
decisions regarding the ongoing operations of the
business.
Retail segment adjusted gross profit percentage is calculated as
Retail segment adjusted gross profit divided by Retail segment
revenue.
|
|
|
|
2024
|
|
|
|
2023
|
|
|
|
|
(16
weeks)
|
|
|
|
(16 weeks)
|
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
Retail
|
Financial
Services
|
Elimi-
nations
|
Total
|
|
|
|
Retail
|
Financial
Services
|
Elimi-
nations
|
Total
|
(millions of Canadian
dollars)
|
|
Revenue
|
|
|
$
|
18,259
|
$
382
|
$ (103)
|
$
18,538
|
|
|
$
|
17,982
|
$ 379
|
$ (96)
|
$ 18,265
|
Cost of
sales
|
|
|
|
12,617
|
48
|
—
|
12,665
|
|
|
|
12,480
|
54
|
—
|
12,534
|
Gross profit
|
|
|
$
|
5,642
|
$
334
|
$ (103)
|
$
5,873
|
|
|
$
|
5,502
|
$ 325
|
$ (96)
|
$
5,731
|
Adjusted gross
profit
|
|
|
$
|
5,642
|
$
334
|
$ (103)
|
$
5,873
|
|
|
$
|
5,502
|
$ 325
|
$ (96)
|
$
5,731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Operating Income, Adjusted EBITDA and Adjusted
EBITDA Margin The following tables reconcile adjusted
operating income and adjusted EBITDA to operating income, which is
reconciled to net earnings attributable to shareholders of the
Company as reported in the consolidated statements of earnings for
the periods ended as indicated. The Company believes that adjusted
EBITDA is useful in assessing the performance of its ongoing
operations and its ability to generate cash flows to fund its cash
requirements, including the Company's capital investment
program.
Adjusted EBITDA margin is calculated as adjusted EBITDA divided
by revenue.
|
|
|
|
2024
|
|
|
|
2023
|
|
|
|
|
(16
weeks)
|
|
|
|
(16 weeks)
|
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
Retail
|
|
Financial
Services
|
|
Total
|
|
|
|
Retail
|
|
Financial
Services
|
Total
|
(millions of Canadian
dollars)
|
|
|
|
|
Net earnings
attributable to shareholders of the Company
|
|
|
|
|
|
|
$
|
780
|
|
|
|
|
|
|
$
624
|
Add impact of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-controlling
interests
|
|
|
|
|
|
|
|
40
|
|
|
|
|
|
|
25
|
Net interest expense
and other financing charges
|
|
|
|
|
|
|
|
238
|
|
|
|
|
|
|
234
|
Income
taxes
|
|
|
|
|
|
|
|
263
|
|
|
|
|
|
|
182
|
Operating
income
|
|
|
$
|
1,091
|
$
|
230
|
$
|
1,321
|
|
|
$
|
1,006
|
$
|
59
|
$
1,065
|
Add (deduct) impact of
the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
intangible assets acquired with
Shoppers Drug Mart and
Lifemark
|
|
|
$
|
155
|
$
|
—
|
$
|
155
|
|
|
$
|
154
|
$
|
—
|
$ 154
|
Gain on sale of
non-operating properties
|
|
|
|
—
|
|
—
|
|
—
|
|
|
|
(13)
|
|
—
|
(13)
|
Fair value adjustment
on fuel and foreign currency
contracts
|
|
|
|
—
|
|
—
|
|
—
|
|
|
|
(6)
|
|
—
|
(6)
|
Recovery related to PC
Bank commodity tax matter
|
|
|
|
—
|
|
(155)
|
|
(155)
|
|
|
|
—
|
|
—
|
—
|
Adjusting
items
|
|
|
$
|
155
|
$
|
(155)
|
$
|
—
|
|
|
$
|
135
|
$
|
—
|
$ 135
|
Adjusted operating
income
|
|
|
$
|
1,246
|
$
|
75
|
$
|
1,321
|
|
|
$
|
1,141
|
$
|
59
|
$
1,200
|
Depreciation and
amortization
|
|
|
|
891
|
|
12
|
|
903
|
|
|
|
865
|
|
15
|
880
|
Less: Amortization of
intangible assets acquired with
Shoppers Drug Mart and Lifemark
|
|
|
|
(155)
|
|
—
|
|
(155)
|
|
|
|
(154)
|
|
—
|
(154)
|
Adjusted
EBITDA
|
|
|
$
|
1,982
|
$
|
87
|
$
|
2,069
|
|
|
$
|
1,852
|
$
|
74
|
$
1,926
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In addition to the items described in the Retail segment
adjusted gross profit section above, when applicable, adjusted
EBITDA was impacted by the following:
Amortization of intangible assets acquired with
Shoppers Drug Mart and Lifemark The
acquisition of Shoppers Drug Mart in 2014 included
approximately $6,050 million of
definite life intangible assets, which are being amortized over
their estimated useful lives. Annual amortization associated with
the acquired intangibles will be approximately $500 million
until 2024 and will decrease thereafter.
The acquisition of Lifemark in 2022 included approximately
$299 million of definite life
intangible assets, which are being amortized over their estimated
useful lives.
Gain on sale of non-operating properties In the
third quarter of 2024, the Company did not record any gain or loss
related to the sale of non-operating properties (third quarter of
2023 – gain of $13 million).
Fair value adjustment on fuel and foreign currency
contracts The Company is exposed to commodity price
and U.S. dollar exchange rate fluctuations. In accordance with the
Company's commodity risk management policy, the Company enters into
exchange traded futures contracts and forward contracts to minimize
cost volatility relating to fuel prices and the U.S. dollar
exchange rate. These derivatives are not acquired for trading or
speculative purposes. Pursuant to the Company's derivative
instruments accounting policy, changes in the fair value of these
instruments, which include realized and unrealized gains and
losses, are recorded in operating income. Despite the impact of
accounting for these commodity and foreign currency derivatives on
the Company's reported results, the derivatives have the economic
impact of largely mitigating the associated risks arising from
price and exchange rate fluctuations in the underlying commodities
and U.S. dollar commitments.
Recovery related to PC Bank commodity tax matter
In July 2022, the Tax Court
released a decision relating to PC Bank, a subsidiary of the
Company. The Tax Court ruled that PC Bank is not entitled to
claim notional input tax credits for certain payments it made to
Loblaws Inc. in respect of redemptions of loyalty points. PC Bank
subsequently filed a Notice of Appeal with the FCA and in
March 2024, the matter was heard by
the FCA. In August 2024, the FCA
released its decision and reversed the decision of the Tax Court.
As a result, PC Bank reversed charges of $155 million, including $111 million initially recorded in the second
quarter of 2022.
Adjusted Net Interest Expense and Other Financing
Charges The following table reconciles adjusted net
interest expense and other financing charges to net interest
expense and other financing charges as reported in the consolidated
statements of earnings for the periods ended as indicated. The
Company believes that adjusted net interest expense and other
financing charges is useful in assessing the Company's underlying
financial performance and in making decisions regarding the
financial operations of the business.
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
2024
|
|
|
2023
|
(millions of Canadian
dollars)
|
|
|
(16
weeks)
|
|
|
(16 weeks)
|
Net interest expense
and other financing charges
|
|
|
$
238
|
|
|
$
234
|
Add: Recovery related
to PC Bank commodity tax matter
|
|
|
10
|
|
|
—
|
Adjusted net interest
expense and other financing charges
|
|
|
$
248
|
|
|
$
234
|
|
|
|
|
|
|
|
In the third quarter of 2024, $10
million was recorded related to interest income on cash tax
refunds on the PC Bank commodity tax matter discussed
above.
Adjusted Income Taxes and Adjusted Effective Tax
Rate The following table reconciles adjusted income taxes
to income taxes as reported in the consolidated statements of
earnings for the periods ended as indicated. The Company believes
that adjusted income taxes is useful in assessing the Company's
underlying operating performance and in making decisions regarding
the ongoing operations of its business.
Adjusted effective tax rate is calculated as adjusted income
taxes divided by the sum of adjusted operating income less adjusted
net interest expense and other financing charges.
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
2024
(16
weeks)
|
|
|
|
2023
(16 weeks)
|
(millions of Canadian
dollars except where otherwise indicated)
|
|
|
|
|
|
|
Adjusted operating
income(i)
|
|
|
$
|
1,321
|
|
|
$
|
1,200
|
Adjusted net interest
expense and other financing charges(i)
|
|
|
|
248
|
|
|
|
234
|
Adjusted earnings
before taxes
|
|
|
$
|
1,073
|
|
|
$
|
966
|
Income taxes
|
|
|
$
|
263
|
|
|
$
|
182
|
Add impact of the
following:
|
|
|
|
|
|
|
|
|
Tax impact of items
included in adjusted earnings before
taxes(ii)
|
|
|
|
—
|
|
|
|
37
|
Adjusted income
taxes
|
|
|
$
|
263
|
|
|
$
|
219
|
Effective tax
rate
|
|
|
|
24.3 %
|
|
|
|
21.9 %
|
Adjusted effective tax
rate
|
|
|
|
24.5 %
|
|
|
|
22.7 %
|
|
|
|
|
|
|
|
|
|
(i)
|
See reconciliations of
adjusted operating income and adjusted net interest expense and
other financing charges in the tables above.
|
(ii)
|
See the adjusted
operating income, adjusted EBITDA and adjusted EBITDA margin table
and the adjusted net interest expense and other financing charges
table above for a complete list of items included in adjusted
earnings before taxes.
|
Adjusted Net Earnings Available to Common
Shareholders and Adjusted Diluted Net Earnings Per Common
Share The following table reconciles adjusted net earnings
available to common shareholders of the Company and adjusted net
earnings attributable to shareholders of the Company to net
earnings attributable to shareholders of the Company and then to
net earnings available to common shareholders of the Company for
the periods ended as indicated. The Company believes that adjusted
net earnings available to common shareholders and adjusted diluted
net earnings per common share are useful in assessing the Company's
underlying operating performance and in making decisions regarding
the ongoing operations of its business.
For the periods ended
October 5, 2024 and October 7, 2023
|
|
|
|
2024
|
|
|
|
|
2023
|
(millions of Canadian
dollars except where otherwise indicated)
|
|
|
|
(16
weeks)
|
|
|
|
|
(16 weeks)
|
Net earnings
attributable to shareholders of the Company
|
|
|
$
|
780
|
|
|
|
$
|
624
|
Prescribed dividends on
preferred shares in share capital
|
|
|
|
(3)
|
|
|
|
|
(3)
|
Net earnings available
to common shareholders of the Company
|
|
|
$
|
777
|
|
|
|
$
|
621
|
Net earnings
attributable to shareholders of the Company
|
|
|
$
|
780
|
|
|
|
$
|
624
|
Adjusting items (refer
to the following table)
|
|
|
|
(10)
|
|
|
|
|
98
|
Adjusted net earnings
attributable to shareholders of the Company
|
|
|
$
|
770
|
|
|
|
$
|
722
|
Prescribed dividends on
preferred shares in share capital
|
|
|
|
(3)
|
|
|
|
|
(3)
|
Adjusted net earnings
available to common shareholders of the Company
|
|
|
$
|
767
|
|
|
|
$
|
719
|
Diluted weighted
average common shares outstanding (millions)
|
|
|
|
306.9
|
|
|
|
|
318.4
|
|
|
|
|
|
|
|
|
|
|
The following table reconciles adjusted net earnings available
to common shareholders of the Company and adjusted diluted net
earnings per common share to net earnings available to common
shareholders of the Company and diluted net earnings per common
share for the periods ended as indicated.
|
|
|
|
2024
|
|
|
|
2023
|
|
|
|
|
(16
weeks)
|
|
|
|
(16 weeks)
|
For the periods ended
October 5, 2024 and October 7, 2023
(millions of Canadian
dollars/Canadian dollars)
|
|
|
|
Net Earnings
Available to
Common
Shareholders
of the
Company
|
|
Diluted
Net
Earnings
Per
Common
Share
|
|
|
|
Net Earnings
Available to
Common
Shareholders
of the
Company
|
|
Diluted
Net
Earnings
Per
Common
Share
|
|
|
|
|
As
reported
|
|
|
$
|
777
|
$
|
2.53
|
|
|
$
|
621
|
$
|
1.95
|
Add (deduct) impact of
the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
intangible assets acquired with Shoppers Drug Mart and
Lifemark
|
|
|
$
|
115
|
$
|
0.38
|
|
|
$
|
113
|
$
|
0.35
|
Gain on sale of
non-operating properties
|
|
|
|
—
|
|
—
|
|
|
|
(11)
|
|
(0.03)
|
Fair value adjustment
on fuel and foreign currency contracts
|
|
|
|
—
|
|
—
|
|
|
|
(4)
|
|
(0.01)
|
Recovery related to PC
Bank commodity tax matter
|
|
|
|
(125)
|
|
(0.41)
|
|
|
|
—
|
|
—
|
Adjusting
items
|
|
|
$
|
(10)
|
$
|
(0.03)
|
|
|
$
|
98
|
$
|
0.31
|
Adjusted
|
|
|
$
|
767
|
$
|
2.50
|
|
|
$
|
719
|
$
|
2.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Cash Flow The following table reconciles, by
reportable operating segments, free cash flow to cash flows from
operating activities. The Company believes that free cash flow is
the appropriate measure in assessing the Company's cash available
for additional financing and investing activities.
|
|
|
2024
|
|
|
2023
|
|
|
|
(16
weeks)
|
|
|
(16 weeks)
|
For the periods ended
October 5, 2024
and October 7, 2023
|
|
|
Retail
|
|
Financial
Services
|
|
Elimi-
nations(i)
|
|
Total
|
|
|
Retail
|
|
Financial
Services
|
|
Elimi-
nations(i)
|
|
Total
|
(millions of Canadian
dollars)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used
in) operating activities
|
|
|
$
1,829
|
|
$ 75
|
|
$ 54
|
|
$
1,958
|
|
|
$ 1,898
|
|
$
107
|
|
$ 40
|
|
$ 2,045
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital
investments(ii)
|
|
|
675
|
|
15
|
|
—
|
|
690
|
|
|
681
|
|
14
|
|
—
|
|
695
|
Interest
paid(i)
|
|
|
94
|
|
—
|
|
54
|
|
148
|
|
|
82
|
|
—
|
|
40
|
|
122
|
Lease payments,
net
|
|
|
498
|
|
—
|
|
—
|
|
498
|
|
|
472
|
|
—
|
|
—
|
|
472
|
Free cash
flow
|
|
|
$
562
|
|
$ 60
|
|
$ —
|
|
$
622
|
|
|
$
663
|
|
$ 93
|
|
$ —
|
|
$
756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Interest paid is
included in cash flows from operating activities under the
Financial Services segment.
|
(ii)
|
Capital investments are
the sum of fixed asset purchases and intangible asset additions as
presented in the Company's Condensed Consolidated Statements of
Cash Flows, and prepayments transferred to fixed assets in the
current period.
|
Same-Store Sales Same-store sales are retail segment
sales for stores in operation in both comparable periods, including
relocated, converted, expanded, contracted or renovated
stores. The Company believes this metric is useful in
assessing sales trends excluding the effect of the opening and
closure of stores.
SOURCE Loblaw Companies Limited